Lo Steven
- SEC CIK
- 0001501959
No open-market purchases or sales filed in the past year.
Current role at each company
- VXRT Vaxart, Inc.President, Chief Exec Officeras of Mar 26, 2026
- ZSAN Zosano Pharma CorpChief Executive Officeras of Jun 7, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lo Steven as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VXRT Vaxart, Inc.
President, Chief Exec Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 19, 2025 (view filing)6:49 PM ET | May 19 | Same day | Lo StevenPresident, Chief Exec Officer | PPurchase | +100.0K | $0.49 | +$49.0K | New position100.0K after |
ZSAN Zosano Pharma Corp
Chief Executive Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2022 (view filing) | Jun 6 | 1 day | Lo StevenChief Executive Officer | SSale | −442 | $0.71 | −$313.82 | −3.2%13.2K after | |
| Apr 1, 2022 (view filing)9:07 PM ET | Mar 31 | 1 day | Lo StevenChief Executive Officer | SSale | −23.6K | $0.2101 | −$4.97K | −4.9%460.7K after |